Archive | Conferences

ESMO: Merck’s Keytruda tames stage 2 melanoma, reducing cancer recurrence in postsurgery use

Stage 3 melanoma was the first cancer area to have an FDA-approved immunotherapy to prevent disease from returning after surgery.

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

ESMO announces award winners

The European Society for Medical Oncology announced the recipients of this year’s ESMO Awards.

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

For cancer treatment and more, genetic-based precision medicine holds a lot of promise

A month following surgery for thyroid cancer, a Hartford Hospital patient’s tumor grew to 10 inches. The case was presented to the hospital’s tumor board, which involved 30 doctors from different specialties.

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

A new approach to predict the evolutionary mechanisms of melanoma

Melanoma is a malignant tumour resulting from the transformation of melanocytes, the cells in the skin that undertake to synthesise melanin, a complex polymer which protects us from the negative effects of solar radiation.

Read the full story

Posted in Melanoma News, Health Professionals, Conferences